HomeNewsBusinessRecovery visible in aviation sector, pushing for greater manufacturing in India: Jyotiraditya Scindia

Recovery visible in aviation sector, pushing for greater manufacturing in India: Jyotiraditya Scindia

Jyotiraditya Scindia said the aviation industry has received a boost with added infrastructure, pointing out that more regional and last-mile connecting flights have been started, especially linking the northeast region of the country.

November 25, 2022 / 20:00 IST
Story continues below Advertisement

Green shoots are visible in the aviation sector as average passenger traffic has neared pre-COVID levels, along with greater manufacturing and more direct long-haul flights, said India’s Civil Aviation and Steel Minister Jyotiraditya Scindia in an exclusive interview to Moneycontrol.

Speaking to Moneycontrol at his office here, Scindia said the aviation industry has received a boost with added infrastructure, pointing out that more regional and last-mile connecting flights have been started, especially linking the northeast region of the country.

Story continues below Advertisement

The minister, who holds the additional charge of the steel ministry, said that efforts are on to activate advance landing grounds for passenger flights to make air travel a more accessible option.

In terms of traffic growth, the minister said that prior to the pandemic, in 2019-2020, the country had 144 million domestic and 60 million international travellers. “Last month, we had close to about 11.4 million travellers, which means we have come very close to the pre-COVID average, which was 12 million travellers a month,” he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show